Related Experiment Video
Updated: Feb 10, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Understanding hepatitis C
1Gastroenterology and Hepatology Research, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
Insights
Hepatitis C virus (HCV) affects millions globally, causing significant deaths and liver transplants in the US. Long-term infections acquired decades ago will increase future disease burden and healthcare costs.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis C virus (HCV) infection impacts 4 million in the US and 170 million worldwide.
- HCV causes 10,000 annual deaths and is the leading cause of liver transplantation in the US.
- New HCV infections primarily stem from injection drug use (68%) and sexual transmission (18%).
Purpose of the Study:
- To review the virology, serology, epidemiology, and natural history of HCV.
- To analyze the current and projected future disease burden of HCV in the United States.
- To highlight implications for clinicians and pharmacists in managed care settings.
Main Methods:
- Review of existing literature on HCV.
- Analysis of epidemiological data and disease trends.
- Projection of future morbidity, mortality, and costs associated with HCV.
Main Results:
- HCV prevalence is 1.8% in the US, with many unaware of their infection.
- Despite a decline in new infections since the 1990s, long-term infections from the 1960s-1980s will increase future disease burden.
- A proportion of long-term HCV patients will develop cirrhosis, decompensated liver disease, or hepatocellular carcinoma (HCC).
Conclusions:
- The aging cohort of HCV-infected individuals poses a significant future challenge.
- Increased rates of cirrhosis, decompensated liver disease, and HCC are anticipated.
- Managed care settings must prepare for rising HCV-related end-stage liver disease and HCC cases.
Abstract:
There are at least 4 million cases of hepatitis C virus (HCV) infection in the United States (overall prevalence 1.8%, with many of these patients unaware of their infection) and 170 million worldwide. The consequences of this virus account for 10,000 deaths every year in the United States. HCV is the primary reason for liver transplantation in this country. Most new cases are now acquired through the use of illegal injection drugs (68%) or potentially sexual transmission (18%). Although the incidence of HCV infection has dropped sharply since the early 1990s because of improved blood-supply screening, the infections that were acquired from the 1960s to the 1980s are likely to dramatically increase the morbidity, mortality, and costs of HCV disease over the next 2 decades. A proportion of these individuals with long-term HCV infection will develop cirrhosis, decompensated liver disease, or hepatocellular carcinoma (HCC). These increases in HCV-related end-stage liver disease and HCC will have significant implications for clinicians and pharmacists in managed care settings. This article reviews the virology, serology, epidemiology, natural history, and the current and projected future disease burden of HCV in the United States.
Related Concept Videos
Understanding the Self
Understanding Self-Concept
Understanding Deception
Understanding Love
Understanding Consciousness
Sleep, a crucial state, is characterized by reduced...
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...

